NOVC — Nova Cannabis Income Statement
0.000.00%
Last trade - 00:00- CA$108.64m
- CA$158.19m
- CA$259.33m
- 56
- 84
- 60
- 73
Annual income statement for Nova Cannabis, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8.54 | 63.3 | 134 | 226 | 259 |
| Cost of Revenue | |||||
| Gross Profit | 2.7 | 20.8 | 24.9 | 43.9 | 61.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 14.3 | 63.2 | 152 | 234 | 252 |
| Operating Profit | -5.71 | 0.129 | -18 | -7.54 | 7.56 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -5.79 | -2.07 | -20.6 | -11.2 | 3.03 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.7 | -2.07 | -20.6 | -11.2 | 3.03 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.7 | -2.07 | -20.6 | -11.2 | 3.03 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.7 | -2.07 | -20.6 | -11.2 | 3.03 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.324 | -0.053 | -0.293 | -0.1 | 0.102 |